Results 41 to 50 of about 1,374,270 (261)

Pediatric Idiopathic Multicentric Castleman Disease Is Often Severe But Responsive to Siltuximab

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Idiopathic multicentric Castleman disease (iMCD) is a potentially fatal immunologic disorder marked by widespread lymphadenopathy and inflammation. Siltuximab, an interleukin‐6 (IL‐6) inhibitor, is the only FDA‐approved treatment for adult patients with iMCD.
Bridget Austin   +17 more
wiley   +1 more source

Current status and perspectives of the quality system in histocompatibility laboratories in Poland

open access: yesFrontiers in Genetics
Allogeneic transplantation is a multi-step process involving many clinicians and laboratory personnel working together to achieve a common goal—to maximize the recipients’ chance of survival and to improve their quality of life.
Izabela Uhrynowska-Tyszkiewicz   +6 more
doaj   +1 more source

Venetoclax‐Based Therapy as a Bridge to Hematopoietic Stem Cell Transplantation in Relapsed or Refractory Pediatric Acute Leukemia

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Relapsed and/or refractory (R/R) pediatric acute leukemia carries a dismal prognosis, largely driven by chemoresistance to conventional salvage therapy. The BH3‐mimetic venetoclax, combined with chemotherapy or hypomethylating agents, has demonstrated efficacy in small clinical trials.
Katherine S. Colman   +9 more
wiley   +1 more source

Evaluation of antibiogram of bacteria isolated from laboratories and lecture theatres in Bayero University Kano

open access: yesThe Proceedings of the Nigerian Academy of Science, 2022
This study was aimed to evaluate antibiogram of bacteria within 25 laboratories and 16 lecture theatres in Bayero University, Kano (Old and New sites). Samples of air were randomly collected from the two sites.
Yasir H. Bichi   +5 more
doaj   +1 more source

Biphasic Clinical Course of Pediatric Cytomegalovirus‐Associated Immune Thrombocytopenia: Early Poor Treatment Response but Favorable Long‐Term Outcomes

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Cytomegalovirus (CMV) is a recognized trigger of immune thrombocytopenia (ITP); however, its incidence and impact on disease course in children remain controversial. Therefore, we aimed to characterize the clinical course of pediatric patients with CMV‐associated ITP.
Oded Gilad   +9 more
wiley   +1 more source

Corrigendum: The application of sigma metrics in the laboratory to assess quality control processes in South Africa

open access: yesAfrican Journal of Laboratory Medicine, 2023
No abstract avilable.
Marli van Heerden   +2 more
doaj   +1 more source

“We Cannot Talk as a Family”: Complexities of Survivorship Communication Among Hispanic/Latino Young Adult Survivors of Childhood Cancer, Parents, and Clinicians

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Young adult childhood cancer survivors (YA‐CCS) have an increased risk of treatment‐related health complications throughout their lives. Lifelong survivorship care is recommended, yet many YA‐CCS experience disruptions in care during pediatric‐to‐adult transitions and do not receive recommended survivorship care.
Kevin Shanchen Pu   +8 more
wiley   +1 more source

Design and Implementation of real-time virtual and remote control laboratories for virtual and distanced education [PDF]

open access: yesInterdisciplinary Journal of Virtual Learning in Medical Sciences, 2010
Recent advances in computer networks and computer science have created a proper environment to control and monitor systems. With the needs today's society to virtual and distanced educations, developments of virtual universities and an increase in ...
Ali Ghadamyari   +2 more
doaj  

Home - About - Disclaimer - Privacy